What a Post-Fed Rally Could Look Like

U.S. stock futures are trading just below fair value

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

OPENING VIEW     10/29/2019
Our #1 Micro-Cap Stock to Own Today On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. That's why we believe anyone who gets in today could turn every $1,000 into $1.54 million (or more)!
S&P Set to Pull Back From Record High By Josh Selway Share On With earnings dominating the headlines again, Dow Jones Industrial Average (DJI) futures are trading below fair value this morning. Futures on the S&P 500 Index (SPX) are also pointing to a lower open for stocks, as the broad-market index looks set to cool after yesterday's record high. Alphabet's (GOOGL) poorly received earnings update is one reason for the risk-off approach this morning, while traders also digest quarterly reports from Dow components Merck (MRK) and Pfizer (PFE). Continue reading for more on today's market, including:  Schaeffer's Senior V.P. of Research Todd Salamone explains what a post-Fed rally could look like. The bearish signal flashing for FedEx. An FDA update had analysts weighing in on one biotech. Plus, 2 big earnings losers; and Boeing's CEO heads to Washington. >> Continue reading...
LATEST HEADLINES
>> Starbucks Gets Upbeat Analyst Attention Before Earnings SBUX's recent pullback has found support >> $24B Biotech Behemoth Wins Drug Rights in Shocking Bid Click to continue to advertiser's site. >> Downtrending TVIX Keeps Drawing Inflows Traders are dumping capital into the 2x VIX futures tracker as fast as TVIX can burn it up >> S&P Hits New High on Sunny Earnings Reports, China Optimism The Fed is expected to cut rates again at this week's meeting >> Omeros Shorts Squeezed as Stock Pops OMER is trading above a key trendline today Sponsored Tiny Biotech Wins $75 Billion Patent Tiny biotech firm wins $2 billion patent for new treatment that can "Cut & Paste" cancer from your body. The Wall Street Journal reports this breakthrough is "transforming medicine." Our research proves that anyone who gets in by October 25th could turn $1,000 into $1.57 million (or more).   Featured Stock Alert:  ICOTF A Stalking Horse Bid from a ~$24 Billion BioPharma Behemoth Could Breathe Life into this unknown 8 cent stock.   Check this hot stock out HERE!
To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S OPENING VIEW enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com